Methotrexate Tablet
Product Images NDC 59651-182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 59651-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (100 Tablets Bottle))

Package Label-principal Display Panel (2.5 mg (100 Tablets Bottle))
This is a description for Methotrexate Tablets USP, a cytotoxic agent intended for prescription-only use. The tablets come in a container of 100 tablets manufactured by Aurobindo Pharma USA, distributed by Aurobindo Pharma USA, Inc. The container has information for the caregiver regarding dosage and drug information, and the tablets need to be kept in a light-resistant container with a child-proof closure as defined in the USP. More information is available in the prescribing information. The code TSDRUGS 242015 is printed on the container.*
FDA Label Image

Chemical Structure (Methotrexate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.